ICNA PRESIDENT-ELECT ELECTIONS 2024

ICNA President-Elect Elections 2024 are currently underway. All eligible voters (ICNA Full Members) have been emailed their unique voting credentials. All voting is done via the secure platform at https://icnapedia.org/pe2024. The voting site will remain open until 2400hrs GMT on 1 May 2024.

Write a comment
  • News
  • Survey about medical treatment in childhood epilepsy from ILAE's Paediatric Commission Medical Task Force

Survey about medical treatment in childhood epilepsy from ILAE's Paediatric Commission Medical Task Force

Adelina Soares
Updated
Follow

Dear Colleague,

We hope you will take 10-15 minutes to answer this brief survey about medical treatment in childhood epilepsy from ILAE’s Paediatric Commission Medical Task Force.

The aim of the survey is to study your current treatment practices in 6 typical early life epilepsy scenarios. Our aim is not only to show first and second line treatment preferences, but also to illustrate that we commonly use off-label drugs in childhood epilepsies.

Please answer the questions referring to your daily clinical practice (and not what you know from textbooks, guidelines etc). We start with some questions about your current situation followed by the 6 scenarios. For the anti-seizure drugs, please use their generic name and not a  brand name. Please complete the survey only once, as it is possible that you will receive this survey through different channels.

All your personal data will remain anonymized of course.

We would appreciate receiving your responses before October 1!   This is the link to the survey :  https://www.surveymonkey.com/r/MKFTHNG

Thank you for your collaboration!

Lieven Lagae

On behalf of the ILAE Medical Task force:

Alexis Arzimanoglou, Stéphane Auvin, Helen Cross, Hans Hartmann, Ronit Pressler, Kate Riney, Kenji Sugai,  Jo Wilmshurst , Elissa Yozawitz

Say something here...
Log in with ( Sign Up ? )
or post as a guest
Loading comment... The comment will be refreshed after 00:00.

Be the first to comment.